Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 10, 2022 08:30 ET | Source: Vaxcyte, Inc.

Vaxcyte to Present at the 11th Annual SVB Leerink Global Healthcare Conference

SAN CARLOS, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of...
January 13, 2022 01:07 ET | Source: Vaxcyte, Inc.

Vaxcyte Announces Pricing of $100 Million Public Offering

SAN CARLOS, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of...
January 12, 2022 16:10 ET | Source: Vaxcyte, Inc.

Vaxcyte Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

SAN CARLOS, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of...
January 06, 2022 08:30 ET | Source: Vaxcyte, Inc.

Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease

-- Company Expects to Deliver Topline Immunogenicity Results from the Phase 1/2 Clinical Study by End of 2022 -- -- VAX-24 is a 24-Valent Pneumococcal Conjugate Vaccine Candidate Designed to Provide...
November 11, 2021 16:05 ET | Source: Vaxcyte, Inc.

Vaxcyte to Present at Upcoming Investor Conferences

FOSTER CITY, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
November 10, 2021 16:10 ET | Source: Vaxcyte, Inc.

Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update

-- Company Expects to Submit VAX-24 IND Application to FDA in Q1 2022 -- -- Completed Manufacture of VAX-24 GMP Drug Product and GLP Toxicology Study -- FOSTER CITY, Calif., Nov. 10, 2021 (GLOBE...
October 28, 2021 08:30 ET | Source: Vaxcyte, Inc.

Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors

FOSTER CITY, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
September 28, 2021 16:05 ET | Source: Vaxcyte, Inc.

Vaxcyte to Present at Guggenheim 2nd Annual Vaccine and Infectious Disease Conference

FOSTER CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
September 21, 2021 16:01 ET | Source: Vaxcyte, Inc.

Vaxcyte to Present at 2021 Cantor Virtual Global Healthcare Conference

FOSTER CITY, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
September 20, 2021 16:30 ET | Source: Vaxcyte, Inc.

Vaxcyte Appoints Annie Drapeau and Teri Loxam to Its Board of Directors

FOSTER CITY, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...